Eric Peter Milledge
About Eric Peter Milledge
Eric Peter Milledge is a Director at Glassbeam, Inc., where he has worked since 2023. He has extensive experience in the pharmaceuticals and medical devices industry, having held various leadership roles, including Chairman at multiple organizations.
Work at Glassbeam
Eric Peter Milledge currently serves as Director at Glassbeam, Inc., a position he has held since 2023. Prior to this role, he was the Chairman of the Board at Glassbeam from 2021 to 2023. His leadership at Glassbeam has contributed to the company's strategic direction and operational oversight.
Previous Roles and Experience
Before joining Glassbeam, Milledge held various significant positions in the medical and technology sectors. He was the Chairman of the Board at ReShape Medical, Inc. from 2015 to 2017. Additionally, he served as the Chairman of the Scientific Advisory Board at DarioHealth Corp. from 2020 to 2022. His extensive experience includes 11 years as an Operating Partner at Endeavour Vision, where he focused on medtech investments.
Career at Johnson & Johnson
Milledge spent 37 years at Johnson & Johnson, where he held multiple leadership roles, including Company Group Chairman of LifeScan Inc. from 2000 to 2007. He also served as President for eight years, overseeing key operations in the pharmaceuticals and medical device sectors. His tenure at Johnson & Johnson is marked by significant contributions to the company's growth and innovation.
Education and Honors
Milledge studied at Saint Mary's University, where he earned an Honorary Doctorate Degree in Economics in 1994. He has received several honors throughout his career, including the Man of the Year award from the Epilepsy Foundation in 1994 and the Humanitarian of the Year award from the Martin House for Justice Foundation in 1999. He was also recognized as 'Father of the Year' by the American Diabetes Association in 2002.
Leadership in Medtech and Advisory Roles
In addition to his roles at Glassbeam and Johnson & Johnson, Milledge has held influential positions in the medtech industry. He served as Chairman of Symetis S.A. from 2009 to 2016 and was a member of the Board of Directors at ReShape Medical, Inc. His experience has positioned him as a key figure in the growth and development of medical technology investments.